12 Mar 25
The laws and regulations regarding cannabis in Japan have undergone significant changes in recent years. In particular, in 2023, a revised bill was proposed for the Cannabis Control Law, which established a new offence for use and officially approved Epidiolex, a CBD preparation for medical use. The revised law was delayed from the initially scheduled date of October 2024, and then came into effect on 12 December, but expectations for growth in the CBD market temporarily slowed in 2024. This article explains the reasons for this, the current situation, and the outlook for the future market.
Aya Suzuki